Financial and business reports
Transparent and extensive: Annual financial statements, management report and much more at a glance.The annual general meeting of MagForce AG will take place on August 12, 2021 as a virtual general meeting
Video Speech Dr. Ben Lipps, CEOMedia Center
Further information and press material for download in our Media Centre. Browse through numerous interesting videos, photos and documents.
We would be happy to inform you about our company and current developments in our innovative method of treating cancer. We would be happy to answer press and investor inquiries by phone or email.
00 49 30 308380 77
2020
Annual Report 2020
2020
Half-year Report
2019
Annual Report 2019
2019
Half-year Report
2018
Annual Report 2018
2018
Half-year Report
2017
Annual Report 2017
2017
Half-year Report 2017
2016
Annual Report 2016
2016
Half-year Report 2016
2015
Annual Report 2015
2015
Half-year Report 2015
2014
Annual Report 2014
2014
Half-year Report 2014
2013
Annual Report 2013
2013
Half-year Report 2013
2012
Annual Report 2012
2012
Half-year Report 2012
2011
Annual Report 2011
2011
Half-year Report 2011
2010
Annual Report 2010
2010
Half-year Report 2010
2009
Annual Report 2009
2009
Half-year Report 2009
2008
Annual Report 2008
2008
Halbjahresbericht 2008
2007
Annual Report 2007
2007
Half-Year Report 2007
2019
November
Edison Interim results
Stifel (formerly Mainfirst)
30. June 2021
Dr. Marcus Wieprecht
Buy
Hauck & Aufhäuser
11. February 2020
Aliaksandr Halista
Buy
GBC AG Investment Research
20. July 2021
Cosmin Filker, Marcel Goldman
Buy
Edison Research
14. July 2021
Dr. Susie Jana, Dr. John Priestner
Buy
Berenberg Bank
29. June 2020
Tom Jones
Buy
2021
June
Letter to shareholders
2020
October
Letter to shareholders
2020
June
Letter to shareholders
2020
May
Letter to shareholders
2019
October
Letter to shareholders
2019
June
Letter to shareholders
2019
February
Letter to shareholders
2018
October
Letter to shareholders
2018
March
Letter to shareholders
2018
February
Letter to shareholders
2017
September
Letter to shareholders
2017
June
Letter to shareholders
2017
March
Letter to shareholders
2016
September
Letter to shareholders
2016
June
Letter to shareholders
2016
March
Letter to shareholders
2015
September
Letter to shareholders
2015
June
Letter to shareholders
2015
February
Letter to shareholders
2014
November
Letter to shareholders
2014
August
Letter to Shareholders (part of the Half-Year Report 2014)
2014
Juni
Letter to Shareholders (part of the Annual Report 2013)
2014
March
Letter to shareholders
2013
November
Letter to shareholders
2013
July
Letter to shareholders
2021
Voting Results (German)
2021
Presentation of the Annual General Meeting 2021
2021
Addition to the Agenda
2021
Invitation to the AGM 2021 including reports of the Executive Board
2021
Annual report 2020 including the annual financial statements and report of the Supervisory Board
2021
Proxy Appointment and Instruction Form
2020
Presentation of the Annual General Meeting 2020
2020
Invitation to the Annual General Meeting 2020 including reports of the Executive Board
2020
Annual report 2019 including the annual financial statements and report of the Supervisory Board
2020
Power of attorney and instruction to proxies
2020
Power of attorney
2020
Revocation of authorization
2019
Presentation of the Annual General Meeting 2019
2019
Invitation to the Annual General Meeting 2019 including reports of the Executive Board
2019
Annual Report 2018 including the annual financial statements and report of the Supervisory Board
2019
Power of attorney and instructions to proxies
2019
Power of attorney to third parties
2019
Revocation of authorization
2018
Presentation of the Annual General Meeting 2018
2018
Invitation to the Annual General Meeting 2018
2018
Revocation of the authorization
2018
Power of attorney and instructions to proxies.
2018
Power of attorney to third parties
2018
Annual Report 2017 including the annual financial statements and report of the Supervisory Board
2017
Presentation Annual General Meeting 2017
2017
Invitation
2017
Power of attorney and instructions to proxies
2017
Authority to third party
2017
Revocation of the authorization
2017
Annual Report 2016 including the annual financial statements and the report of the Supervisory Board
2016
Presentation of the Annual General Meeting 2016
2016
Invitation
2016
Power of attorney and instructions to proxies
2016
Authority to third party
2016
Revocation of the authorization
2016
Annual Report 2015 including the annual financial statements and the report of the Supervisory Board
2015
Presentation of the 2015 Annual General Meeting
2015
Annual Report for the year 2014
2014
Presentation of the 2014 Annual General Meeting
2014
Annual Report for 2013
2021
10. March
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014
2021
08. February
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014
2020
15. December
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014
2020
10. December
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014
2020
24. June
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014
2020
27. April
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014
2019
31. December
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014
2019
11. September
MagForce AG publishes Directors' Dealings
2019
06. September
MagForce AG publishes Directors' Dealings
2019
06. September
MagForce AG publishes Directors' Dealings
2019
27. August
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014
2019
27. June
MagForce AG publishes Directors' Dealings
2019
25. June 2019
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014
2019
31. May
MagForce AG publishes Directors' Dealings
2019
27. May
MagForce AG publishes Directors' Dealings
2019
27. May
MagForce AG publishes Directors' Dealings
2019
27. May
MagForce AG publishes Directors' Dealings
2019
20. May
MagForce AG publishes Directors' Dealings
2019
20. May
MagForce AG publishes Directors' Dealings
2019
16. May
MagForce AG publishes Directors' Dealings
2019
14. May
MagForce AG publishes Directors' Dealings
2019
10. May
MagForce AG publishes Directors' Dealings
2019
09. May
MagForce AG publishes Directors' Dealings
2018
08. August
MagForce AG announces successful capital increase of US subsidiary MagForce USA, Inc.
2018
17. May
MagForce AG publishes Directors' Dealings
2018
03. May
MagForce AG publishes Directors' Dealings
2018
14. February
MagForce AG publishes Directors' Dealings
2018
13. February
MagForce AG publishes Directors' Dealings
2018
10. February
MagForce USA receives approval from the FDA to conduct a clinical trial of NanoTherm® focal tumor ablation therapy for intermediate-risk prostate cancer
2017
27. October
MagForce AG publishes Directors' Dealings
2017
16. August
MagForce AG publishes Directors' Dealings
2017
16. August
MagForce AG publishes Directors' Dealings
2017
14. August
MagForce AG publishes Directors' Dealings
2017
08. August
Insider information: MagForce AG concludes financing agreement with the European Investment Bank
2017
28. June
Insider information: MagForce AG successfully places capital increase from authorized capital
2017
28. June
Insider information: MagForce AG approves capital increase from authorized capital, excluding subscription rights
2017
09. May
Magforce AG publishes Directors' Dealings
2017
05. May
MagForce AG publishes Directors' Dealings
2016
11. October
MagForce AG publishes Directors' Dealings
2016
06. October
MagForce AG publishes Directors' Dealings
2016
05. October
MagForce AG publishes Directors' Dealings
2016
30. September
MagForce AG publishes Directors' Dealings
2016
30. August
MagForce AG publishes Directors' Dealings
2016
09. August
MagForce AG publishes Directors' Dealings